Universal directly observed therapy: A treatment strategy for tuberculosis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Patient adherence to prescribed tuberculosis regimens must be assured to prevent relapse, acquired resistance, and transmission. Directly observed therapy (DOT), an outpatient management strategy designed to ensure adherence, is not widely used because it is perceived to be inordinately expensive. The primary focus of this article is on using universal, as opposed to selective, DOT in the treatment of tuberculosis patients. Universal DOT is a policy where it is intended that observed therapy be used for all patients. Selective DOT is a policy where patients are observed taking medications only if certain selection criteria are satisfied. Topics addressed include cost, efficacy, nonadherence, and implementation guidelines.

Original languageEnglish
Pages (from-to)155-163
Number of pages9
JournalClinics in Chest Medicine
Volume18
Issue number1
DOIs
StatePublished - 1 Jan 1997

Fingerprint

Directly Observed Therapy
Tuberculosis
Therapeutics
Patient Compliance
Patient Selection
Outpatients
Guidelines
Costs and Cost Analysis
Recurrence

Cite this

@article{ac45acac5cf4445788d1d52fa332c66e,
title = "Universal directly observed therapy: A treatment strategy for tuberculosis",
abstract = "Patient adherence to prescribed tuberculosis regimens must be assured to prevent relapse, acquired resistance, and transmission. Directly observed therapy (DOT), an outpatient management strategy designed to ensure adherence, is not widely used because it is perceived to be inordinately expensive. The primary focus of this article is on using universal, as opposed to selective, DOT in the treatment of tuberculosis patients. Universal DOT is a policy where it is intended that observed therapy be used for all patients. Selective DOT is a policy where patients are observed taking medications only if certain selection criteria are satisfied. Topics addressed include cost, efficacy, nonadherence, and implementation guidelines.",
author = "Stephen Weis",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0272-5231(05)70365-8",
language = "English",
volume = "18",
pages = "155--163",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Universal directly observed therapy : A treatment strategy for tuberculosis. / Weis, Stephen.

In: Clinics in Chest Medicine, Vol. 18, No. 1, 01.01.1997, p. 155-163.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Universal directly observed therapy

T2 - A treatment strategy for tuberculosis

AU - Weis, Stephen

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Patient adherence to prescribed tuberculosis regimens must be assured to prevent relapse, acquired resistance, and transmission. Directly observed therapy (DOT), an outpatient management strategy designed to ensure adherence, is not widely used because it is perceived to be inordinately expensive. The primary focus of this article is on using universal, as opposed to selective, DOT in the treatment of tuberculosis patients. Universal DOT is a policy where it is intended that observed therapy be used for all patients. Selective DOT is a policy where patients are observed taking medications only if certain selection criteria are satisfied. Topics addressed include cost, efficacy, nonadherence, and implementation guidelines.

AB - Patient adherence to prescribed tuberculosis regimens must be assured to prevent relapse, acquired resistance, and transmission. Directly observed therapy (DOT), an outpatient management strategy designed to ensure adherence, is not widely used because it is perceived to be inordinately expensive. The primary focus of this article is on using universal, as opposed to selective, DOT in the treatment of tuberculosis patients. Universal DOT is a policy where it is intended that observed therapy be used for all patients. Selective DOT is a policy where patients are observed taking medications only if certain selection criteria are satisfied. Topics addressed include cost, efficacy, nonadherence, and implementation guidelines.

UR - http://www.scopus.com/inward/record.url?scp=0030935020&partnerID=8YFLogxK

U2 - 10.1016/S0272-5231(05)70365-8

DO - 10.1016/S0272-5231(05)70365-8

M3 - Article

C2 - 9098620

AN - SCOPUS:0030935020

VL - 18

SP - 155

EP - 163

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 1

ER -